Archives

  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2018-07
  • (S)-(+)-Dimethindene maleate: Technical Guide for M2 Antagon

    2026-04-27

    (S)-(+)-Dimethindene maleate: Technical Best Practices for Selective M2 Antagonism

    What This Product Solves

    (S)-(+)-Dimethindene maleate (SKU B6734) is a small-molecule antagonist with high selectivity for the muscarinic acetylcholine receptor subtype M2 and additional antagonism at histamine H1 receptors. This selectivity enables researchers to probe muscarinic acetylcholine receptor signaling pathways with minimal interference from M1, M3, or M4 subtypes, which is essential for studies in autonomic regulation research, cardiovascular physiology studies, and respiratory system function research (product_spec). The compound’s dual receptor profile allows dissection of overlapping cholinergic and histaminergic responses in complex tissue or cell models. Its solid form, water solubility, and high purity (98%) further support reproducible assay development for pharmacological and receptor selectivity profiling workflows.

    For expanded perspectives on practical applications in cell-based assays and large-scale extracellular vesicle production, refer to this internal article, which details experimental scenarios and troubleshooting for SKU B6734. Strategic considerations for translational workflows and biomanufacturing are reviewed in this related article.

    Protocol Parameters

    • Receptor binding/functional assays | 20.45 mg/mL (water solubility) | Suitable for in vitro binding or cellular response studies | Ensures rapid and complete dissolution for accurate dosing; avoids precipitation artifacts | product_spec
    • Stock solution preparation | Use immediately after reconstitution; do not store long-term | Applicable for all experimental setups using aqueous solutions | Prevents compound degradation and variability in active concentration | product_spec
    • Storage (solid form) | Room temperature, desiccated | Long-term compound maintenance in laboratory settings | Preserves chemical integrity and potency prior to use | product_spec
    • Working concentration | Empirical, recommend titration within assay-specific context | For pharmacological profiling and cell-based assays | Optimal concentration varies with receptor density and system sensitivity; start in low micromolar range and adjust as needed | workflow_recommendation

    Workflow Setup and QC Checklist

    • Upon receipt, confirm product identity (SKU B6734) and purity (98%) against the manufacturer's specification.
    • Store unopened vials at room temperature in a desiccated environment to avoid hydrolysis or degradation.
    • Weigh solid compound using a calibrated microbalance. Prepare fresh stock solutions in sterile water immediately before use, ensuring concentrations do not exceed 20.45 mg/mL to avoid solubility issues.
    • Filter sterilize solutions for cell culture applications if sterility is required.
    • Do not freeze or refrigerate stock solutions; use within the same experimental session.
    • Document lot number and preparation date for traceability in all experimental records.
    • Validate selectivity with appropriate negative and positive controls, especially in muscarinic acetylcholine receptor signaling pathway studies.

    Common Failure Modes and Fixes

    • Precipitation in stock solutions: If compound fails to dissolve at target concentration, confirm water is at room temperature and increase mixing time. Avoid exceeding 20.45 mg/mL.
    • Loss of activity in stored solutions: Decreased antagonistic effect may result from storing aqueous stocks beyond recommended use period. Always prepare fresh solutions immediately before each experiment.
    • Off-target effects: Use matched controls and titrate concentrations to confirm selective M2 antagonism. If unexpected responses occur, review assay design for potential interference from other receptor subtypes.
    • Batch variability: Trace all experiments by lot number and cross-check purity documentation for each shipment.

    Scope and Limitations

    (S)-(+)-Dimethindene maleate is validated for in vitro research applications focused on autonomic regulation, cardiovascular, and respiratory system studies. It is not intended for diagnostic, therapeutic, or clinical applications. Selectivity is highest for the M2 muscarinic receptor, but researchers should empirically confirm specificity within their own assay context, especially in complex biological samples. Long-term storage of solutions is not supported; only the solid form is suitable for extended retention (product_spec). No direct paper-based evidence for human or animal administration is available; all recommendations derive from product and workflow documentation.

    Conclusion

    (S)-(+)-Dimethindene maleate provides a reliable option for selective muscarinic M2 receptor antagonism and histamine H1 blockade in basic and translational research. Careful adherence to preparation, storage, and QC protocols ensures high data integrity and reproducibility (APExBIO). This product is best employed in receptor pharmacology workflows, with clear boundaries for use outside diagnostic or clinical contexts.